The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Characteristics of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Male predominance, propensity for extramedullary involvement, and poor outcomes.
Naveen Pemmaraju
No relevant relationships to disclose
Deborah A. Thomas
No relevant relationships to disclose
Hagop M. Kantarjian
No relevant relationships to disclose
Jorge E. Cortes
No relevant relationships to disclose
Joseph Khoury
No relevant relationships to disclose
John T Manning
No relevant relationships to disclose
L Jeffrey Medeiros
No relevant relationships to disclose
Susan Mary O'Brien
No relevant relationships to disclose
Naval Guastad Daver
No relevant relationships to disclose
Sherry Pierce
No relevant relationships to disclose
Guillermo Garcia-Manero
No relevant relationships to disclose
Elias Jabbour
No relevant relationships to disclose
Nitin Jain
No relevant relationships to disclose
Muzaffar H. Qazilbash
No relevant relationships to disclose
Stefan Faderl
No relevant relationships to disclose
Arthur E. Frankel
Research Funding - Stemline Therapeutics
Other Remuneration - Stemline Therapeutics
Marina Konopleva
Research Funding - Stemline Therapeutics